checkAd
    Startseite > Aktien > Optimi Health > Nachrichten
    Optimi Health Aktie
    0,3800
     
    CAD
    +8,57 %
    +0,0300 CAD
    Letzter Kurs 08.05.24 CSE
    0,3750
     
    CAD
    2.500 STK
    Geldkurs 08.05.24
    0,3800
     
    CAD
    76.500 STK
    Briefkurs 08.05.24
    ISIN: CA68405H1001 · WKN: A2QQEL · SYM: OPTI · Kanada

    Neueste Nachrichten

    Optimi Health and Kwantlen Polytechnic University Applied Genomics Centre Partner to Advance Mushroom Science and Research
    23.04.24 · globenewswire · Optimi Health
    Optimi Health Achieves Milestone: Completes In-House Production of MDMA Active Pharmaceutical Ingredient (API)
    15.04.24 · globenewswire · Optimi Health
    Optimi Health Signs Psilocybin Supply Agreement With New Zealand-Based Mātai Medical Research Institute
    09.04.24 · globenewswire · Optimi Health
    Optimi Health Receives Finished Product Test Results and Certificate Of Analysis for GMP Natural Psilocybin Extract
    02.04.24 · globenewswire · Optimi Health
    Optimi Health Confirms Presenting Sponsorship at the 4th Annual Psychedelic Therapeutics and Drug Development Conference
    28.03.24 · globenewswire · Optimi Health
    Optimi Health to Supply MDMA for Psychedelic Research at Tel Aviv University
    26.03.24 · globenewswire · Optimi Health
    Optimi Announces Closing of First Tranche of Non-Brokered Private Placement
    28.02.24 · globenewswire · Optimi Health
    Optimi Health Congratulates Lykos Therapeutics on FDA Priority Review of New Drug Application And Releases MDMA Production Video
    12.02.24 · globenewswire · Optimi Health
    Optimi Announces Non-Brokered Private Placement
    08.02.24 · globenewswire · Optimi Health
    Optimi Health To Host MDMA Educational Quality Assurance Webinar For Clinicians And Practitioners
    06.02.24 · globenewswire · Optimi Health
    Optimi Health sichert sich ergänzende Zulassung zur Steigerung der Produktionsmengen von MDMA, MDA und 2C-B im Rahmen seiner Händlerlizenz für kontrollierte Arzneimittel und Substanzen
    22.01.24 · IRW Press · Optimi Health
    Optimi Health Secures Amendment to Increase Quantities Of MDMA, MDA, And 2C-B Under Controlled Drugs And Substances Dealer’s Licence
    19.01.24 · globenewswire · Optimi Health